KiOmed Pharma is a Belgian biotech company specializing in the development, manufacture, and distribution of safe and effective medical devices. With over 10 years of research and innovation, KiOmed Pharma has created a unique pipeline of products to address debilitating conditions such as OsteoArthritis, skin aging, and eye disorders. At the core of their technology is Carboxymethyl Chitosan (CM-chitosan), a medical-grade natural chitosan derivative that offers numerous advantages.

This patented KiOmedine® technology provides excellent lubrication properties, tissue protection against oxidative stress, and good scavenging capacity. It brings high clinical value to therapeutic solutions and is suitable for both injectable formulations and implantable devices. KiOmed Pharma's focus areas include: 01.

OsteoArthritis: Their technology is an effective component to tackle discomfort and symptoms associated with OsteoArthritis, a degenerative joint disease that affects millions worldwide. 02. Skin Aging: KiOmedine®-based dermal fillers provide tunable tissue filling properties, unique skin protection, hydration, and collagen synthesis stimulation.

03. Eye Disorders: With its hydrating and lubricating properties, KiOmedine® is a preferred choice for eyedrops formulations and innovative treatments for the posterior segment of the eye. Supported by a multidisciplinary team of experts, KiOmed Pharma is dedicated to advancing innovative solutions to meet unmet needs in the treatment of these conditions.

They prioritize safety and efficacy and have undergone rigorous pre-clinical and clinical studies to demonstrate the superiority of their technology. Contact KiOmed Pharma to learn more about their groundbreaking products and solutions